Pfizer Sells “Booster” Jabs to Israel as COVID Cases Rebound

“Despite boasting higher adult vaccination rates than any other developed nation, Israel is scrambling to stanch a resurgence of new COVID infections after the country’s top scientists revealed that they believed the Pfizer vaccine is only 64% effective at preventing infections involving the Delta variant currently stoking problems across the globe.”

Pfizer Sells “Booster” Jabs To Israel As COVID Cases Rebound | ZeroHedge

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: